By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A start-up company led by a former Critical Path Institute official has received $1.5 million in private equity funding, according to a filing with the Securities and Exchange Commission.

The company, United States Diagnostics Standards, or USDS Inc., was founded by Jeffrey Cossman, who served as chief scientific officer of C-Path and directed the public-private consortium's Washington, DC-area office.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.